Micah Thorp is a Nephrology physician. OpenAlex indexes 74 publications with 2,371 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6902 SE Lake Rd
Milwaukie, OR 972672148
Telephone
503-232-4465Provider last certified this registry record 23 Aug 2022.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20251 payment
- Galderma Laboratories, L.P.Program year20241 payment
- AbbVie Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.9%Calcium channel blocker10.7%Amlodipine Besylate78%Nifedipine Er22%Part D<11 patientsAngiotensin receptor blocker (ARB)8.6%Losartan Potassium100%Part D≥27 patients+ 7 more classes in this area
Metabolism & gastrointestinal
20.9%SGLT2 inhibitor7.3%Jardiance100%Part D≥19 patientsCorticosteroid5%Prednisone100%Part D≥13 patients+ 4 more classes in this area
Nervous system
10.4%Gabapentinoids3.8%Gabapentin100%Part D≥11 patientsBenzodiazepine3.7%Temazepam100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicted risk of renal replacement therapy at arteriovenous fistula referral in chronic kidney disease
The Journal of Vascular Access
2020 - Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation
Clinical Journal of the American Society of Nephrology
2016 - A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
American Journal of Kidney Diseases
2015 - A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
American Journal of Kidney Diseases
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”